Delta Investment Management’s Maravai LifeSciences MRVI Stock Holding History

Delta Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$870K	Sell	307,371 -108,229	-26%	-$367K	0.16%	104
2025 Q4	$1.35M	Sell	415,600 -54,540	-12%	-$184K	0.23%	78
2025 Q3	$1.35M	Sell	470,140 -39,801	-8%	-$102K	0.24%	74
2025 Q2	$1.23M	Buy	509,941 +66,252	+15%	+$139K	0.24%	76
2025 Q1	$981K	Buy	443,689 +110,696	+33%	+$437K	0.2%	70
2024 Q4	$1.81M	Buy	332,993 +246,592	+285%	+$1.59M	0.35%	50
2024 Q3	$718K	Buy	+86,401	New	+$747K	0.15%	91

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Delta Investment Management's MRVI Position: Q1 2026 in Review

Delta Investment Management reduced its Maravai LifeSciences (MRVI) stake by 26% in Q1 2026, selling an estimated $367K and leaving 307,371 shares worth $870K. The position accounts for 0.16% of the portfolio, ranked #104.

Delta Investment Management first reported a position in MRVI in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.81M in Q4 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Delta Investment Management held 307,371 shares of Maravai LifeSciences worth $870K as of Q1 2026.
Delta Investment Management sold 108,229 Maravai LifeSciences shares in Q1 2026, an estimated $367K.
Maravai LifeSciences made up 0.16% of Delta Investment Management's portfolio in Q1 2026, its #104 holding.
Delta Investment Management first reported a position in Maravai LifeSciences in Q3 2024 and has held it in 7 quarters since.
Delta Investment Management's Maravai LifeSciences position peaked at $1.81M in Q4 2024.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Delta Investment Management's 13F filing for Q1 2026, filed 13 May 2026.